Meningococcal Disease Vaccines Market Set to Increase Due to Government and Private Healthcare Initiatives

Meningococcal disease is a catastrophic infection that spreads through the Neisseria meningitides bacteria. The disease occurs due to aggravation of the pathogenicity of the bacteria due to seasonal variations and is a life-threatening illness. Meningococcal disease occurs when meninges, the thin lining surrounding the brain and spinal cord, are severely infected. Vaccines for immunization have helped save millions of lives and are considered the most effective method of prevention of many communicable diseases.

Five serogroups of bacteria cause the invasive global meningococcal disease vaccines market. The serogroups mainly exist in humans in a dormant state and eventually cause the disease due to factors such as environment or immunogenic causes. The most prominent serogroups are A, B, C, Y, and W-135. The serogroups occur in variations based on age, geographical locations, and time. The disease can result in death within 24 hours from the onset of symptoms and is contagious. The disease has a high mortality rate and is fatal if not diagnosed or treated.

Browse Full Global Meningococcal Disease Vaccines Market Research Report With Complete TOC @ http://www.transparencymarketresearch.com/meningococcal-vaccines-market.html

Bexsero, Trumenba, NmVac4 DT Vaccines Lead Meningococcal Disease Vaccines Market

Vaccines are the best known preventive measures for meningococcal disease and there are vaccines available for prevention of meningitis, meningococcemia, and septicemia. Bexsero by Novartis and Trumenba by Pfizer are vaccines that have been recently approved in the U.S. in January 2015, and October 2014, respectively. Novartis was allowed to market Bexsero for serogroup B in Europe, Canada, and Australia. NmVac4 DT is a conjugate vaccine against meningococcal disease has been developed against the serogroups A, C, Y and W-135. This vaccine is animal component free, which could increase its demand post launch.

Vaccines for meningococcal disease include types such as combination vaccines, polysaccharide, and conjugate that are segmented into different brands. Among these, polysaccharide vaccines are the oldest available, being formulated three decades ago. Conjugate vaccines have been widely used and have significantly reduced the prevalence of bacterial meningitis due to the prolonged immunity achieved against the disease-causing serogroups, as compared to polysaccharide vaccines, which provide immunity for a very short period. The use of combination vaccines to combat two bacterial infections, for use against invasive meningococci, is being used effectively in the current scenario.

Browse the full Press Release report: http://www.transparencymarketresearch.com/pressrelease/meningococcal-vaccines-market.htm

Increased Preventive Measures Fuel Market for Meningococcal Disease Vaccines

Due to the medical emergency status of the meningococcal disease, there is an increased demand for preventive vaccines. The increased number of people needing immunization and awareness campaigns run by governments, non-profit organizations, and manufacturers in developed economies have contributed to the increased demand for the vaccines. In certain countries, governments have introduced immunization programs for school children, Haj pilgrims, and sub-Saharan travelers resulting in increased demand for meningococcal vaccines. A recent market research study indicates that the global market for meningococcal vaccines was valued at US$1,537.3 million in 2013 and analysis shows an expected rise to US$4,450.4 million in 2022 at a CAGR of 12.4 % from 2014 to 2022.

Geographical distribution of the global meningococcal vaccines market includes four regions: North America, Europe, Asia Pacific, and Rest of the World (RoW). Major countries in these regions are part of the sub-segmentation of these areas. North America was the largest market for meningococcal vaccines in terms of revenue in 2013. The fastest growing market for the vaccines is considered to be Asia Pacific, followed by Rest of the World (RoW).

Request a Brochure of this Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=1666

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.